This book provides patients and their physicians (especially non-oncologist health care
providers) with a clear and concise introduction to cancer immunotherapy which unlike
traditional forms of cancer therapy acts by boosting the patient's own immune system to fight
cancer. The unique features of cancer immunotherapy make its management monitoring and
side-effects different from those of traditional cancer therapy. Especially novel are the side
effects of cancer immunotherapy necessitating greater awareness for both patients and
physicians in order to minimize complications of therapy. The patient-friendly concise
easy-to-understand and up-to-date knowledge presented in this book will inform patients about
the benefits and risks of cancer immunotherapy and help them and their care providers to
understand how immunotherapy would control their unique disease. Researchers and academic
professionals in the field of cancer immunotherapy will also find clear and usefulinformation
to help them communicate with patients or address unresolved problems. Some key features of the
book are: Expertise. All editors and authors are scientists and oncologists specializing in
cancer immunotherapy and are involved in scientific discovery from the early stage of
immune-checkpoint inhibitors to today's daily patient care. Their insights expertise and
experience guarantee the high quality and authority in the science medicine and practice of
cancer immunotherapy. Patient-friendly. This book is written for cancer patients in order to
meet their needs when considering immunotherapy. As an educational tool this book will help
the reader balance the risks and benefits based on both science and clinical facts and
therefore to make the best choice in receiving or withdrawing from immunotherapy. Disease
Specificity. Cancer is a complicated disease involving multiple stages and pathology.Its
response to immunotherapy is individualized and varies depending on cancer types. The authors'
expertise in treating different types of cancers including melanoma lung kidney bladder
and lymphoma provides disease-specific insights in applying immunotherapy to each disease.
